Showing results (91-100 of 172) with videos related to
Sort By:
Pageof 18
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 7, 2014
Prognostic significance of miRNA-1 (miR-1) expression in patients with chordomaZhenfeng Duan, Jacson Shen, Xiaoqian Yang, et al.Spine|May 13, 2010
Characterization and analysis of human chordoma cell linesCao Yang, Francis J Hornicek, Kirkham B Wood, et al.Journal of Surgical Oncology|September 17, 2016
Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcomaGeorge Molina, Melissa A Hull, Yen-Lin Chen, et al.Cancer|December 20, 2011
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomasJohn T Mullen, Wendy Kobayashi, Jing Jing Wang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2018
Clinicopathologic characteristics of poorly differentiated chordomaAngela R Shih, Gregory M Cote, Ivan Chebib, et al.Cancer|August 2, 2014
Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapyJohn T Mullen, Francis J Hornicek, David C Harmon, et al.Plos One|July 2, 2014
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1Edwin Choy, Laura E MacConaill, Gregory M Cote, et al.Plos One|November 30, 2017
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlatesGonzalo Lopez, Danielle Braggio, Abeba Zewdu, et al.Annals of Surgical Oncology|February 13, 2010
Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomasSam S Yoon, Yen-Lin Chen, David G Kirsch, et al.The Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.Pageof 18